Disease and portfolio strategy to maximize long-term value

Navigate disease complexity, map future scenarios and make the portfolio choices that shape investment, development and lifecycle success. 

Connect with our Experts

Specialists in Disease & Portfolio Healthcare Consulting

Our team combines extensive expertise and experience in healthcare consulting. Get to know our Disease & Portfolio strategy-to-impact partners.

Ben Rigby

Associate Partner

Deborah Lough

Associate Partner

Khushbu Goulden

Associate Partner

David Coleiro

Partner

Maxine Smith

Head of Practice - Partner

Lee Griffiths

Associate Partner

Joshua Roche

Associate Partner

Strategic blueprints for high-stakes portfolio decisions

Disease and portfolio strategy require a clear view of where the market is heading, how opportunities could evolve and which choices will create the greatest long-term value. We help teams define the strategic vision, future scenarios and decision frameworks needed to guide development, investment and resource allocation across the lifecycle. 

By connecting disease area insight, portfolio priorities, competitive dynamics and commercial opportunity, we help teams align around where to focus and how to maximize value across brands, indications and assets. Our disease and portfolio strategy capabilities help you make confident decisions across: 

Disease area strategy​

Portfolio strategy​

BD assessment​

Indication sequencing and strategy​

Provide an overarching vision and purpose within a therapeutic landscape to serve as the North Star that guides development and investment decisions.​​​

Co-create the strategy that guides cross-portfolio prioritization, clinical development plan (CDP) decisions and resource allocation to ensure full alignment.​​​​

Apply a systematic, data-driven approach to identifying external commercial opportunities and selecting assets that best fit the existing or future portfolio.​​​​

Clarify strategic choices and timeline mechanics across multiple brands, indications and assets to optimize long-term revenue and protect lifetime asset value.​​​​​


The decisions we help you make

Customer Insights and Understanding

What will shape customer decisions, shift behavior and unlock growth? 

How do we navigate disease complexity, map future scenarios and maximize the value of our entire portfolio? 

How do we build the capabilities, behaviors and tools to make strategy stick? 

Where should we focus, how do we win and what choices create the greatest value? 

How do we create actionable plans that sustain differentiation and drive outcomes? 

What future are we planning for, and where can this asset win? 

How do we launch with confidence, agility and measurable uptake? 

News and Insights

Explore our latest insights, whitepapers, and event highlights to learn more about the latest developments and perspectives shaping the evolving healthcare landscape.

Discover all
Whitepaper

Psychedelic Medicines: The Next Strategic Frontier for Pharma 

Find out more
Blog

The Prescient Disease Area Strategy Impact Index 

Find out more
Blog

Building a Portfolio Approach to Indication Development & Commercialisation

Find out more
Blog

When Pipelines Overlap, Indecision Becomes the Risk

Find out more
Blog

Maximizing Portfolio Value: AI Augmented Strategy Development for Smarter Commercialization 

Find out more

Ready to turn strategy into measurable impact?

The life sciences landscape is full of complexity, but you don't have to navigate it alone. As your strategy-to-impact partner, we are here to help you see further, go deeper and deliver impact where it counts. 

Connect with our experts